Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel and Carboplatin in Locally Advanced Breast Cancer
NCT01625429Phase 2Unknown
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Jun 2012
- Primary completion
- Sep 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Fudan University Shanghai Cancer Center. Status: unknown.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01625429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625429.